Skip to main content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiallergic agent

Histamine H₁-receptor antagonist (H₁-antihistaminic)

Chemical Name

1H-Indene-2-etanamine, N,N-dimetyl-3-[1-(2-pyridinyl)etyl]-

Foreign Names

  • Dimetindenum (Latin)
  • Dimetinden (German)
  • Dimétindène (French)
  • Dimetindeno (Spanish)

Generic Names

  • Dimetindene (OS: DCIT, BAN)
  • Dimétindène (OS: DCF)
  • Dimethylpyrindene (IS)
  • Dimethindene Maleate (OS: USAN)
  • Dimetindene Maleate (OS: JAN)
  • Dimetindine Maleate (OS: BANM)
  • Su 6518 (IS)
  • Dimethindene Maleate (PH: USP XX)
  • Dimétindène (maléate de) (PH: Ph. Eur. 9)
  • Dimetindene Maleate (PH: BP 2018)
  • Dimetindene maleate (PH: Ph. Eur. 9)
  • Dimetindeni maleas (PH: Ph. Eur. 9)
  • Dimetindenmaleat (PH: Ph. Eur. 9)

Brand Names

  • Betiden
    Belupo, Bosnia & Herzegowina
  • Dermacutan
    Santa-Farma, Turkey
  • Fenistil
    Glaxo Group, Slovenia; GlaxoSmithKline, Latvia; GlaxoSmithKline, Netherlands; Novartis, Lebanon; Novartis Consumer Health, Egypt; Novartis Consumer Health, Peru; Novartis Hellas, Cyprus; Wellcome Limited, Bosnia & Herzegowina
  • Fenistil 0.1%
    Novartis, Egypt
  • Fenistil 1mg
    GSK, Luxembourg
  • Fenistil 1mg/g
    GSK, Luxembourg
  • Fenistil 24
    Novartis Finland, Lithuania
  • Grivix
    Medana, Lithuania
  • Vibrocil [+ Phenylephrine]
    Novartis, Egypt; Novartis, Lebanon; Novartis Consumer Health, Malta
  • Balpic
    Baldacci, Portugal
  • Fenakut 1 mg/ml
    GSK-Gebro Consumer Healthcare, Austria
  • Fenedim
    Ariti, Greece
  • Feniallerg 1mg/ml
    GSK Consumer Healthcare, Switzerland
  • Fenistil
    GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Lithuania; GlaxoSmithKline, Portugal; GlaxoSmithKline, Romania; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline A.B.E.E., Greece; GlaxoSmithKline Consumer Healthcare, Germany; GlaxoSmithKline Consumer Healthcare, Spain; GlaxoSmithKline Malta, Malta; GSK, Belgium; GSK, Slovakia; GSK Consumer Healthcare, Czech Republic; Novartis, Georgia; Novartis, Greece; Novartis, Macedonia; Novartis Consumer Health, Israel; Novartis Consumer Health, Italy; Novartis Consumer Health, Poland; Novartis Consumer Health - Gebro, Austria; Novartis PHarma Services Inc., Serbia; Novartis Pharmaceuticals, Kuwait; Sterling, Indonesia
  • Fenistil 0.1%
    GlaxoSmithKline Consumer Healthcare, Bulgaria; GSK Consumer Healthcare, Switzerland; Novartis, Oman; Novartis Hellas, Cyprus; Novartis Pharma, Bulgaria
  • Fenistil 1 mg/g
    GlaxoSmithKline, Hungary
  • Fenistil 1mg
    Novartis, Oman; Novartis Consumer Health - Gebro, Austria
  • Fenistil 1mg/g
    GlaxoSmithKline Consumer Healthcare, Bulgaria; Novartis Pharma, Bulgaria
  • Fenistil Junior 1 mg/ml [pediatric]
    GlaxoSmithKline, Hungary
  • Fenistil PR 4mg
    Novartis, Oman
  • Foristal
    Novartis, India
  • Grivix
    Medana, Latvia
  • Otriduo Schnupfen [+ Phenylephrine]
    GSK Consumer Healthcare, Switzerland
  • Otrivin Allergia [+ Phenylephrine]
    GlaxoSmithKline, Hungary
  • Otrivin Allergy [+ Phenylephrin]
    Novartis Consumer Health, Poland
  • Rinocil [+ Phenylephrine]
    Rubikon, Georgia
  • Vibragel [+ Phenylephrine]
    Novartis, Paraguay
  • Vibrocil [+ Phenylephrine]
    GlaxoSmithKline, Hungary; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Latvia; GlaxoSmithKline, Portugal; GlaxoSmithKline, Romania; GlaxoSmithKline Consumer Healthcare, Belgium; GlaxoSmithKline Consumer Healthcare, Bulgaria; GlaxoSmithKline Consumer Healthcare, Luxembourg; GSK Consumer Healthcare, Switzerland; GSK Consumer Healthcare, Czech Republic; GSK-Gebro Consumer Healthcare, Austria; Novartis, Georgia; Novartis, Slovakia; Novartis Consumer Health, Peru; Novartis Consumer Health, South Africa; Novartis Pharma, Bulgaria; Novartis Pharmaceuticals, Kuwait
  • Vibrocil-S [+ Phenylephrine]
    GlaxoSmithKline A.B.E.E., Greece; Novartis, Greece; Novartis Hellas, Cyprus


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.